GLP1R and type 2 diabetes mellitus: The highest mean baseline EQ-5D index value was found in participants from trials in type 2 diabetes mellitus of glucagon-like peptide-1 receptor agonists and sodium glucose co-transporter 2 inhibitors 0.92 (0.09).